Evaluation of the Cunningham Panel™ in pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS): Changes in antineuronal antibody titers parallel changes in patient symptoms
Frye, Richard E
Latimer, M Elizabeth
Dunn, Joshua P
AffiliationUniv Arizona, Phoenix Childrens Hosp, Barrow Neurol Inst, Dept Child Hlth,Coll Med Phoenix
Basal ganglia encephalitis
Basal ganglia encephalopathy
MetadataShow full item record
CitationShimasaki, C., Frye, R. E., Trifiletti, R., Cooperstock, M., Kaplan, G., Melamed, I., ... & Traver, D. (2020). Evaluation of the Cunningham Panel™ in pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS): Changes in antineuronal antibody titers parallel changes in patient symptoms. Journal of Neuroimmunology, 339, 577138.
JournalJOURNAL OF NEUROIMMUNOLOGY
Rights© 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractComparison of pre- and post-treatment status revealed that the Cunningham Panel results correlated with changes in patient's neuropsychiatric symptoms. Based upon the change in the number of positive tests, the overall accuracy was 86%, the sensitivity and specificity were 88% and 83% respectively, and the Area Under the Curve (AUC) was 93.4%. When evaluated by changes in autoantibody levels, we observed an overall accuracy of 90%, a sensitivity of 88%, a specificity of 92% and an AUC of 95.7%. Assay reproducibility for the calcium/calmodulin-dependent protein kinase II (CaMKII) revealed a correlation coefficient of 0.90 (p < 1.67 × 10-6) and the ELISA assays demonstrated test-retest reproducibility comparable with other ELISA assays.
NoteOpen access article
VersionFinal published version
- Biomarkers for diagnosis of Pediatric Acute Neuropsychiatric Syndrome (PANS) - Sensitivity and specificity of the Cunningham Panel.
- Authors: Hesselmark E, Bejerot S
- Issue date: 2017 Nov 15
- Antineuronal antibodies in a heterogeneous group of youth and young adults with tics and obsessive-compulsive disorder.
- Authors: Cox CJ, Zuccolo AJ, Edwards EV, Mascaro-Blanco A, Alvarez K, Stoner J, Chang K, Cunningham MW
- Issue date: 2015 Feb
- Prevalence of Acute-Onset Subtypes in Pediatric Obsessive-Compulsive Disorder.
- Authors: Jaspers-Fayer F, Han SHJ, Chan E, McKenney K, Simpson A, Boyle A, Ellwyn R, Stewart SE
- Issue date: 2017 May
- Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS)
- Authors: Orefici G, Cardona F, Cox CJ, Cunningham MW, Ferretti JJ, Stevens DL, Fischetti VA
- Issue date: 2016
- Effect of Early and Prophylactic Nonsteroidal Anti-Inflammatory Drugs on Flare Duration in Pediatric Acute-Onset Neuropsychiatric Syndrome: An Observational Study of Patients Followed by an Academic Community-Based Pediatric Acute-Onset Neuropsychiatric Syndrome Clinic.
- Authors: Brown KD, Farmer C, Freeman GM Jr, Spartz EJ, Farhadian B, Thienemann M, Frankovich J
- Issue date: 2017 Sep